Fresenius Gets Win In Suit Over Hospira Sedative Patents
An Illinois federal judge has invalidated parts of two patents covering a "ready-to-use" version of Hospira Inc.'s sedation drug Precedex, opening the door for Fresenius Kabi USA LLC to potentially launch...To view the full article, register now.
Already a subscriber? Click here to view full article